Réactivité et communication des décisions de pharmacovigilance des autorités de santé vers les professionnels de santé : exemples du pergolide et du célécoxib
Thérapie, 62 6 (2007) 513-517
Published online: 2008-03-04
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Did the pattern of use of zolpidem change since the enforcement of a new prescription rule? A latent class analysis using the French health insurance database
Marion Istvan, Morgane Rousselet, Edouard-Jules Laforgue, Marylène Guerlais, Marie Gérardin, Pascale Jolliet, Fanny Feuillet and Caroline Victorri-VigneauExpert Opinion on Drug Safety 21 (9) 1225 (2022)
https://doi.org/10.1080/14740338.2022.2047930
Perception of the Regulatory Change for Zolpidem Prescription by French General Practitioners and Its Relation to Prescription Behavior
Edouard-Jules Laforgue, Marion Istvan, Benoit Schreck, Marie Mainguy, Pascale Jolliet, Marie Grall-Bronnec and Caroline Victorri-VigneauJournal of Clinical Medicine 11 (8) 2176 (2022)
https://doi.org/10.3390/jcm11082176
An Update on Zolpidem Abuse and Dependence
Caroline Victorri-Vigneau, Marie Gérardin, Morgane Rousselet, et al.Journal of Addictive Diseases 33 (1) 15 (2014)
https://doi.org/10.1080/10550887.2014.882725
Relevance of a “Dear Doctor letter” to alert healthcare providers to new recommendations for vitamin D administration
Hélène Théophile, Ghada Miremont-Salamé, Philip Robinson, et al.European Journal of Clinical Pharmacology 67 (7) 681 (2011)
https://doi.org/10.1007/s00228-011-1055-y
Pharmacoepidemiological research using French reimbursement databases: yes we can!
Karin Martin‐Latry and Bernard BégaudPharmacoepidemiology and Drug Safety 19 (3) 256 (2010)
https://doi.org/10.1002/pds.1912